Reaction
Investigation reporting signals
As of the last recalculation, Investigation appears in 3,136 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is DARBEPOETIN ALFA (PRR 71.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Darbepoetin Alfa | 491 | 71.5 | 72.2 |
| Fondaparinux Sodium | 46 | 38.3 | 38.5 |
| Pegfilgrastim | 392 | 30.0 | 30.1 |
| Fluticasone Propionate And Salmeterol | 124 | 20.5 | 20.6 |
| Pazopanib Hydrochloride | 79 | 19.9 | 19.9 |
| Fluticasone Propionate And Salmeterol Xinafoate | 139 | 16.0 | 16.1 |
| Romiplostim | 28 | 12.4 | 12.5 |
| Eltrombopag Olamine | 34 | 9.9 | 9.9 |
| Paliperidone Palmitate | 44 | 9.2 | 9.2 |
| Enzalutamide | 68 | 7.8 | 7.8 |
| Ivacaftor | 9 | 7.5 | 7.5 |
| Denosumab | 210 | 7.3 | 7.3 |
| Lapatinib | 13 | 5.6 | 5.6 |
| Salmeterol Xinafoate | 7 | 5.4 | 5.4 |
| Deferasirox | 21 | 5.3 | 5.3 |
| Epoprostenol | 10 | 5.1 | 5.1 |
| Atovaquone | 6 | 5.0 | 5.0 |
| Amphetamine | 6 | 4.8 | 4.8 |
| Teduglutide | 9 | 4.4 | 4.4 |
| Riociguat | 21 | 4.3 | 4.3 |
| Paliperidone | 15 | 4.3 | 4.3 |
| Dabrafenib | 12 | 3.8 | 3.8 |
| Dolutegravir Sodium | 5 | 3.7 | 3.7 |
| Sodium Oxybate | 32 | 3.2 | 3.2 |
| Trametinib | 10 | 2.8 | 2.8 |
| Bosentan | 18 | 2.4 | 2.4 |
| Abiraterone Acetate | 14 | 2.3 | 2.3 |
| Paricalcitol | 4 | 1.9 | 1.9 |
| Cinacalcet Hydrochloride | 13 | 1.9 | 1.9 |